Intelligent Bio Solutions plans multilingual upgrade for drug screening system, aims to reach 4B users

INTELLIGENT BIO SOLUTIONS INC.

Multilingual upgrade will support languages across Americas, Europe, Asia Pacific, and Middle East, accessible to over 4 billion speakers worldwide.
Supports planned 2025 entry into US market following FDA 510(k) submission in December 2024.
Company has existing presence in 19 countries; targets safety-critical industries like construction, mining, and transport.
Drug screening market projected to reach approximately $8 billion globally by 2030.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.